The waaJ, waaT, and waaR genes encode α-1,2-glycosyltransferases involved in synthesis of the outer core region of the lipopolysaccharide of Escherichia coli. They belong to glycosyltransferase CAZy family 8, characterized by the GT-A fold, DXD motifs, and by retention of configuration at the anomeric carbon of the donor sugar. Each enzyme adds a hexose residue at the same stage of core oligosaccharide backbone extension. However, they differ in the epimers for their donor nucleotide sugars, and in their acceptor residues. WaaJ is a UDPglucose:(galactosyl) LPS α-1,2-glucosyltransferase, whereas WaaR and WaaT have UDP-glucose:(glucosyl) LPS α-1,2-glucosyltransferase and UDPgalactose:(glucosyl) LPS α-1,2-galactosyltransferase activities, respectively. The objective of this work was to examine their ability to utilize alternate donors and acceptors.
His 6 -WaaT, His 6 -WaaJ showed a significantly decreased k cat and increased K M(acceptor) . These results illustrate the differences in behavior between closely related glycosyltransferase enzymes involved in the synthesis of similar glycoconjugates and have implications for for glycoengineering applications.
Bacteria produce a variety of glycoconjugates. The diversity in their structures is afforded by an unparalleled range of glycosyltransferase enzymes that transfer sugars from activated donor substrates to acceptor substrates. Bacterial enzymes have provided some influential models to assess glycosyltransferase structure and function because of the relative ease of their manipulation. One source of glycosyltransferase diversity is lipopolysaccharide (LPS) 1 assembly and the focus of this study is the enzymes involved in biosynthesis of the core oligosaccharide region (core OS). The outer leaflet of the Gram-negative outer membrane contains LPS as a major component. LPS is comprised of three structural domains: lipid A, core OS, and O antigen (1) . E. coli isolates produce one of five core OS types: K-12, R1, R2, R3, and R4 (reviewed in (2) ) and there are at least two core OS types in Salmonella isolates (3) . The backbone of the inner (lipid A proximal) core OS is typically conserved and the various core types primarily arise from differences in inner core substitution and the structure of the part of the outer core which provides the attachment site for O antigen. The genetic basis for these differences has been described (3, 4) .
However, moving from the experimentally derived polysaccharide structure to the assignment of a specific glycosyltransferase involved in a particular linkage is not straightforward. Even when candidate genes have been identified, their DNA sequences alone cannot predict which donor or acceptor substrates will be used by the glycosyltransferase. Experiments involving in vivo complementation of chromosomal insertion mutants and subsequent PAGE analysis of LPS patterns do not necessarily directly address which gene product is producing the LPS alteration, nor do they identify the donor substrate used (5) . Of the known and predicted outer core OS glycosyltransferases from E. coli, only WaaJ has undergone in vitro characterization with both native substrates and purified enzyme (6) .
Bacterial core OS biosynthesis requires the concerted action of specific glycosyltransferase enzymes. The outer core OS biosynthesis glycosyltransferases in E. coli provide an interesting collection of related (predicted) enzymes to examine principles of substrate (UDP-sugar) and linkage specificity ( Fig. 1) . WaaJ catalyzes the addition of an α-1,2-linked Glc to the outer core OS in R3 E. coli (7) and Salmonella enterica serovar Typhimurium (5) and the kinetic properties of the E. coli enzyme have been investigated (6) . The related WaaT enzyme adds an α-1,2-linked Gal to the outer core OS in R1 and R4 E. coli (8) , whereas WaaR is required for the addition of an α-1,2-glucose to the outer core OS in K-12 and R2 E. coli (8) . While WaaJ, WaaR, and WaaT all belong to glycosyltransferase CAZy family 8 (http://www.cazy.org/) and catalyze the same α-1,2 linkage of the donor sugar to their lipid-linked acceptors, they utilize different UDP-sugar donor substrates and have different terminal sugars on their acceptor LPS. However the predicted activities for WaaR and WaaT have not been examined directly. Here we examine the donor and acceptor specificity of these glycosyltransferases enzymes in a combination of in vivo and in vitro approaches in order to generate a better understanding of their substrate specificities and the potential for their manipulation in glycoengineering.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids -The prototypes for the R1, R2 and R3 core OSs are E. coli F470, F632, and F653 respectively; all are rough mutants, i.e. lacking O antigen (9) . CWG350 (waaJ::aacC1) is a derivative of F653 (7). CWG309 (waaT::aacC1) and CWG308 (waaO::aacC1) are derivatives of F470 (8) . These mutants have been described previously and are marked by the gentamycin-resistance cassette (aacC1). E. coli TOP10 cells F -mcrA Δ(mrr-hsdRMS-mcrBC) f80ΔlacZM15 ΔlacX74 deoR recA1 araD139 Δ(araleu)7697 galU galK rpsL (Str r ) endA1 nupG were purchased from Invitrogen and used for expression of the glycosyltransferases.
Plasmid pWQ272 is a pBAD18-derivative (10) containing the coding sequence for an Nterminally hexahistidine-tagged His 6 -WaaJ fusion protein and was previously reported (6) . Plasmid pWQ269 is a derivative of pBAD18 engineered to contain a plasmid-encoded ribosome binding site and N-terminal His 6 -tag 5' of the multicloning site in an organization identical to pWQ272 (Supplemental Table 1 ). The waaR and waaT genes were amplified by PCR and cloned into pWQ269. Plasmid pWQ270 contains the coding sequence for His 6 -WaaR amplified from E. coli F632 genomic DNA (purified using the InstaGene kit, BioRad), while pWQ271 contains the coding sequence for His 6 -WaaT from pWQ905 (8) . All oligonucleotides were synthesized by Sigma Genosys (Oakville, ON) and are listed in Supplementary Table 1 . The sequences of all of the constructs were confirmed to be errorfree by sequencing at the Guelph Molecular Supercenter (University of Guelph).
Complementation Experiments to Assess In Vivo
Activity of His 6 -Waa* Derivatives-Function of the various glycosyltransferases was established by electrotransformation of E. coli CWG350 (waaJ::aacC1), CWG309 (waaT::aacC1) and CWG308 (waaO::aacC1) with plasmids encoding the appropriate Waa* glycosyltransferase. Cultures of transformed bacteria were grown overnight at 37°C in LB containing 100 µg/mL ampicillin and 0.1 mL aliquots were then used to inoculate 5 mL cultures of the same medium supplemented with 0.02% L-arabinose to induce expression from the pBAD promoter in pBAD18 (10) . After growth at 37°C for five hours, SDS-proteinase K whole-cell lysate samples were made following the procedure of Hitchcock and Brown (11) . LPS molecular species in these samples were then separated by electrophoresis using 4-12% gradient NuPage gels (Invitrogen). Electrophoresis was carried out at 150 V for 75 minutes. The gels were silver-stained using standard methods (12) . The extent of complementation was determined by scanning the gels using a Bio-Rad GS-800 Calibrated Densitometer and determining the relative amounts of the two major bands with QuantityOne software.
Production and Purification of LPS and Core

Oligosaccharides-
The LPS (3453 g/mol calculated molecular weight CWG350 LPS; 3368 g/mol calculated molecular weight CWG309 LPS) was purified from F653, CWG350, CWG309, CWG350 (pWQ271), CWG350 (pWQ270), and CWG309 (pWQ272). The LPS was extracted from cells harvested from 6 L cultures and isolated by phenol/chloroform/petroleum ether method (13), as previously described (7) . The isolated LPS was frozen and lyophilized. Working stocks for in vitro assays were stored as 2 mg/mL or 5 mg/mL aqueous solutions at -20°C. Lipid A was removed by treating LPS (100 mg) in 5 mL of 2% AcOH at 100 °C for 3 h. Lipid A was removed as a precipitate by centrifugation, and soluble products were separated on a Sephadex G-50 column (2.5 x 95 cm) eluted in pyridinium/acetate buffer, pH 4.5 (4 mL of pyridine and 10 mL of AcOH in 1 L of water). The eluate was monitored using a refractive index detector. The samples were then filtered through a SepPak C18 column (Waters) in water. Anion-exchange chromatography was performed on a 5 mL Hitrap Q column (Amersham) in water for 10 min, then in linear gradient of 0 to 1 M NaCl over 60 min. with UV detection at 220 nm.
In order to obtain a cleaner NMR spectrum, core oligosaccharide from CWG309 (pWQ272) (5 mg) was dephosphorylated by 48% aqueous hydrofluoric acid (0.1 mL) for 20 h at 4 °C. The HF was removed under a stream of nitrogen, and the product was then desalted by gel-chromatography on a Sephadex G-15 column (1.6 x 80 cm) column using the pyridinium acetate buffer, pH 4.5 (4 mL pyridine and 10 mL AcOH in 1 L water) as eluent. The eluant was monitored by a refractive index detector and collected fractions were then lyophilized before use. Compositional and Methylation Analysis -For compositional analysis, oligosaccharides were hydrolyzed in 4 M CF 3 CO 2 H (120 °C, 3 h), and monosaccharides were converted into the alditol acetate derivatives. The products were analyzed by gas-liquid chromatography (GC) on an Agilent 6850 chromatograph equipped with DB-17 (30 m x 0.25 mm) fused-silica column using a temperature gradient of 180 °C (2 min) to 240 °C at 2 °C/min. Methylation analysis was performed using CiucanuKerek procedure (14). Methylated products were hydrolyzed, and the monosaccharides were converted to 1d-alditol acetates by conventional methods and analyzed by GC-MS. GC-MS was performed on Varian Saturn 2000 system equipped with an ion-trap mass spectral detector using the same column. NMR Spectroscopy-NMR spectra were recorded at 25 °C in D 2 O on a Varian UNITY INOVA 600 instrument using acetone as reference ( 1 H, 2.225 ppm and 13 C, 31.45 ppm). Varian standard programs COSY, NOESY (mixing time of 300 ms), TOCSY (spinlock time 120 ms), HSQC, and gHMBC (evolution delay of 100 ms) were used with digital resolution in F2 dimension <2 Hz/point for protonproton correlations. Spectra were assigned using the computer program Pronto. The chemical shift data is presented in Supplementary Table 2 according to the labelling scheme in Supplementary Fig. 1 .
Mass Spectrometry-
CE-MS spectra were acquired using a 4000 QTrap mass spectrometer (Applied Biosystems/Sciex, Concord, ON, Canada) with CE injection system (Prince Technologies, Netherlands). CE separation was obtained on a 90 cm length of bare fused-silica capillary (365 µm OD x 50 µm ID) with CE-MS coupling using a liquid sheath-flow interface and isopropanol:methanol (2:1) as the sheath liquid. An aqueous buffer consisting of 30 mM morpholine was used for all experiments in the negative-ion mode. The MS data are presented in Supplementary Table 3 . Overexpression, Localization and Purification of Waa* Proteins-Overexpression and cellular location of the His 6 -WaaT and His 6 -WaaR enzymes was monitored by Western immunoblotting, essentially as described previously for His 6 -WaaJ (6). Cell-free lysates of E. coli CWG309 containing pWQ271 and E. coli TOP10 containing pWQ270 were separated by ultracentrifugation. The soluble fraction was collected and the membrane pellet was washed twice with 2 mL 50 mM Tris-HCl pH 7.5. The fraction volumes were adjusted to facilitate direct comparison of the amount of membrane protein corresponding to a given amount of soluble protein. Protein samples were separated by SDS-PAGE and transferred onto PVDF membrane. The Western immunoblots were developed using HisProbe H3 mouse anti-His 6 primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and goat anti-mouse alkaline phosphataseconjugate secondary antibody (Jackson ImmunoResearch Laboratories, Inc., Montréal, QB). Nitro blue tetrazolium from Sigma and 5-bromo-4-chloro-3-indolylphosphate from Roche were used as substrates to develop the Western blots. The bands were quantified by densitometry using a Bio-Rad GS-800 Calibrated Densitometer with QuantityOne software.
The purification of His 6 -WaaJ from overexpression in E. coli TOP10 cells has been described elsewhere (6) . Purification of His 6 -WaaT was done in a similar fashion using Ni 2+ -NTA affinity chromatography, except batch binding was done directly using cell-free lysate, without prior removal of membrane material. In addition, 150 mM NaCl and 7.5 mM imidazole were included in the lysis buffer during sonication and in initial washing of the affinity column. The purified proteins were dispensed in 0.2 mL aliquots for single-use, and total protein concentration was determined using the Bio-Rad Protein Assay with bovine serum albumin as the standard. His 6 -WaaJ and His 6 -WaaT were stable in this form at 4°C for periods of up to 2 weeks. Storage at -20°C offered no additional stability and enzyme samples thawed after storage at -80°C showed significant loss of activity. It should be noted that the level of overexpression of His 6 -WaaT was lower than His 6 -WaaJ. Yields of purified protein were also compromised by the tendency of His 6 -WaaT to adsorb to filters used in concentration. In Vitro Determination of the Activity of His 6 -Waa* Enzymes-The activity of the various constructs was determined as previously described (6) . The reaction is based on the transfer of radioactivity from UDP-[ 14 C-Glc] (Perkin Elmer, 200.0 mCi/mmol) or UDP-[ 14 CGal] (Perkin Elmer, 258.0 mCi/mmol) donor to an acceptor comprising the LPS isolated from E. coli CWG350 (waaJ::aacC1) or CWG309 (waaT::aacC1). Final reaction conditions after the addition of enzyme were: 1-750 µM UDP-sugar donor, 2-750 µM LPS, 100 mM Tris pH 7.5, 0.4 mM EDTA, 5 mM MgCl 2 and 200-900 nM His 6 -WaaJ or His 6 -WaaT in a final volume of 0.1 mL. The His 6 -WaaJ or His 6 -WaaT concentration was adjusted to ensure that it was always at least five-fold below the lowest substrate concentration. The rates at each substrate concentration were then fit to the Michaelis-Menten equation to determine k cat and K M . These values should be considered as "apparent" due to the stopped nature of the assay.
RESULTS
Comparison of WaaJ, WaaR, and WaaT Sequences-
Previous work from our lab established the in vivo and in vitro properties of WT WaaJ (6) . The purpose of this work is to expand that analysis to other CAZy family 8 glycosyltransferases involved in E. coli LPS biosynthesis, particularly ones employing alternate donor sugars and terminal acceptor linkages.
As might be anticipated for E. coli LPS core oligosaccharide biosynthesis proteins that all belong to glycosyltransferase family 8, WaaJ, WaaR, and WaaT share significant primary sequence identity (~40%) and similarity (~60%) and several highly conserved regions (Supplementary Figure 2) . The sequences of these proteins predict no transmembrane helices. However, their nascent lipid A-core OS acceptor is membrane-associated, indicating that a membrane association might be beneficial for activity. His 6 -WaaT was found to be 75% membrane-associated and His 6 -WaaR was found to be 64% membrane-associated (data not shown), compared to 55% for His 6 -WaaJ (6). As described for WaaJ (6), the WaaT and WaaR sequences could be threaded onto the LgtC crystal structure with good alignment of secondary structure (data not shown), but the difference in primary sequences limited the usefulness of this information and precluded and meaningful prediction of residues that might dictate specificity. Function of His 6 -Waa* Derivatives In Vivo-To investigate whether His 6 -WaaT, His 6 -WaaJ, and His 6 -WaaR could function to extend waaJ::aacC1 or waaT::aacC1 LPS in vivo, plasmids encoding the relevant protein were transformed into CWG350 (waaJ::aacC1) and CWG309 (waaT::aacC1) and the resulting LPS profile was investigated by silverstained PAGE. As shown in Fig. 2 , WaaR was able to extend the LPS acceptor from CWG350 (waaJ::aacC1) to generate a product that comigrated with the wildtype LPS, despite the fact that the native acceptor residue for WaaR is a 1,3-linked Glc, rather than the 1,3-linked Gal provided by CWG350 LPS. The CWG350 LPS acceptor lacks three hexose residues (see below) compared to the wildtype and migrates significantly faster, thus WaaR is able to form a product that can then be further extended by additional glycosyltransferases. WaaT was also able to extend the 1,3-linked Gal acceptor but the product remained smaller than the wildtype; its migration was consistent with the absence of a single residue. Each of the glycosyltransferases was able to extend the 1,3-linked Glc acceptor provided by CWG309 (waaT::aacC1) LPS to restore a wildtype profile, indicating that WaaW (Fig. 1) could utilize their products to add the final core OS residue in the F470 (R1 core OS) background.
To further probe the acceptor specificities, each of these enzymes were expressed in CWG308 (waaO::aacC1) cells. Interestingly, no core OS extension occurred in this mutant (Fig. 2C) . Despite the observation (above), indicating that WaaJ, WaaR, and WaaT did not discriminate between 1,3-linked Gal or 1,3-linked Glc acceptors, the enzymes are apparently sensitive to the position of the acceptor residue in the context of the core OS structure.
While silver-stained PAGE LPS profiling is a facile method to test the ability of a protein to extend a given LPS, it does not give any information about the identity of the sugars added. In order to identify the sugars added in the above LPS extensions, LPS was isolated from CWG350, CWG350 (pWQ271), CWG350 (pWQ270), CWG350 (pWQ272), and CWG309 (pWQ272). The structures of the LPS molecules were determined by NMR and MS methods (Supplementary Tables 2 and 3 ). The resulting structures are shown graphically in Fig. 3 . The CWG350 LPS contains a Gal-(1,2)-Glc outer core and lacks the 2 terminal residues expected from the waaJ mutation (Fig. 1) . Also missing is the side-chain GlcNAc residue. This result was consistent with the PAGE profile with respect to the size of the products but differs from the CWG350 structure obtained previously, where traces of GlcNAc were reported (7) . The NMR analysis of the CWG350 core OS was repeated and no evidence of the GlcNAc residue could be detected; there was no detectable peak corresponding to an N-acetyl group. Moreover, the MS data also reflected a core OS species lacking GlcNAc. The reason for this disparity between the structures of CWG350 is unknown and the results shown below indicate that the currently unidentified transferase required for GlcNAc addition (7) is still active in the strains used here.
In CWG350 cells expressing either WaaR or WaaJ, the authentic LPS structure was restored. WaaR is normally a UDP-glucose:(glucosyl) LPS α-1,2-glucosyltransferase. However, when active in the context of CWG350, it shows UDPglucose:(galactosyl) LPS α-1,2-glucosyltransferase activity. As expected, the LPS molecule resulting from WaaR or WaaJ activity serves as an acceptor for WaaD and the still unidentified GlcNAc transferase to complete the core OS structure. In contrast, WaaT added only a single residue to CWG350 LPS. While WaaT is a UDPgalactose:(glucosyl) LPS α-1,2-galactosyltransferase in its wildtype background, in CWG350 it exhibits UDP-galactose:(galactosyl) LPS α-1,2-galactosyltransferase activity. It therefore retains its normal donor specificity but can effectively utilize a different acceptor. The resulting product is not further extended by either WaaD or the GlcNAc transferase, indicating that these transferases are either sensitive to perturbations in acceptor structure, or lose critical protein-protein interactions when the precise combination of glycosyltransferase enzymes changes. CWG309 cells expressing WaaJ were able to form a complete core OS. However, Glc was incorporated as the second-to-last hexose in the core OS backbone.
WaaJ is normally a UDPglucose:(galactosyl) LPS α-1,2-glucosyltransferase. Thus, in the CWG309 background, WaaJ shows UDP-glucose:(glucosyl) LPS α-1,2-glucosyltransferase activity. This demonstrates that, like WaaT and WaaR, it also retains its normal donor specificity in a heterologous background. The published structure for CWG309 core OS lacks the β-Glc sidechain, suggesting this residue is added late in the assembly process (8) . The full extension of the CWG309 (pWQ272) LPS product implies that WaaV and WaaW are unaffected by the local changes in their acceptor structure. This differs from the situation described above for WaaD acting in CWG350 (Fig. 1) .
In Vitro Kinetic Behavior of His 6 -WaaJ and His 6 -WaaT Proteins-
The in vivo results demonstrate two basic principles: (i) His 6 -WaaT, His 6 -WaaR, and His 6 -WaaJ have a marked preference for their specific donor substrates; (ii) these enzymes appear to have a relaxed specificity for alternate LPS acceptor residues, providing the overall size of the acceptor is conserved. His 6 -WaaJ and His 6 -WaaT were therefore selected for in vitro analysis to more precisely determine the effect of alternate donor and acceptor substrates on their kinetic properties. Those results are summarized in Table 1 .
The results of His 6 -WaaJ assays with UDP-Glc and its native (CWG350 (waaJ::aacC1)) LPS acceptor were reported previously (6) . As expected, changing the donor substrate to UDP-Gal resulted in significant drop in enzyme activity, reflected in a 6-fold decrease in k cat and 6-fold increase in K M(donor) . Interestingly, the K M(LPS) also more than doubled, despite the fact that the identity of the LPS in each experimental series was identical. Therefore, changing the donor altered not only the K M(donor) and k cat , but, surprisingly, also the parameters for the acceptor, K M(LPS) . In all cases, the enzyme preparations were free of an UDPGal-4-epimerase enzyme (15) that might produce the alternate donor in situ and generate misleading results (data not shown).
A similar trend was obtained with His 6 -WaaT using the CWG309 (waaT::aacC1) LPS acceptor but different sugar nucleotide donors. His 6 -WaaT readily used UDP-Gal as the donor sugar, as would be expected since this is the physiological donor in its wildtype background. In contrast, there was a significant decrease in k cat when UDP-Glc was used instead. Unfortunately, full kinetic characterization was not possible for this reaction condition. The lower overexpression of His 6 -WaaT and its tendency to adsorb to membrane filters limited the ability to reach high stock concentrations of the protein. The decrease in the activity of His 6 -WaaT with UDP-Glc was so severe that at the protein concentrations reached, the signal was only slightly (but reproducibly) above background at the highest substrate concentrations tested. Therefore, no k cat or K M(LPS) are reported. Nevertheless, the value for K M(UDP-Glc) can be estimated to be greater than 300 µM, since no radioactive incorporation was detected at donor substrate concentrations lower than this value.
The effect of changing the LPS acceptor on His 6 -WaaJ activity was studied with UDP-Glc and purified CWG309 (waaT::aacC1) LPS. The K M(donor) was identical and while the k cat did decrease 3-fold, it still remains twice the value obtained with the physiological acceptor and the alternate (UDP-Gal) donor. The K M(LPS) increased 3-fold relative to its physiological LPS acceptor. Based on the NMR data and LPS PAGE profile of the LPS products, these changes are apparently insufficient to prevent His 6 -WaaJ from fully processing CWG309 (waaT::aacC1) LPS acceptor in vivo.
The effect of changing the LPS acceptor on His 6 -WaaT activity was studied with UDP-Gal and purified CWG350 (waaJ::aacC1) LPS. In contrast to the His 6 -WaaJ results, none of the kinetic parameters of His 6 -WaaT changed markedly when it was examined in assays containing UDP-Gal donor and CWG350 (waaJ::aacC1) acceptor.
DISCUSSION
Glycoconjugates serve roles as diverse as structural components, energy storage, antibiotic diversity and immunological recognition. The specific sugars used and the linkages formed in the glycoconjugates are keys to their function and, due to their biological importance, there has been increasing interest in the commercial-scale synthesis of defined complex carbohydrate structures. Unfortunately, their reactivity and structural and linkage diversity has meant generalized solid phase chemical synthesis for carbohydrates is not as mature a technology as the corresponding methods developed for nucleic acids and peptides (reviewed in (16)).
Therefore, chemical and enzymatic synthesis has been used to create both natural carbohydrates (reviewed in (17)). An understanding of the molecular bases for glycosyltransferase specificity is crucial for engineering glycoconjugates of medical or industrial importance because the inherent specificity potentially limits what can be achieved in enzymatic syntheses.
The group of related glycosyltransferase enzymes from CAZy family 8 provide an excellent opportunity to investigate issues involving substrate specificity. The in vitro kinetic results demonstrate that WaaJ and WaaT have a high selectivity for the correct donor sugar nucleotide. In reactions containing the C4-epimer of the natural donor, k cat is decreased and there are corresponding increases not only in the K M(donor) but also, to a lesser extent, in the K M for the native LPS acceptor. This selectivity is born out by the structure of the in vivo product; the preferred donor substrate is used regardless of the nature of the available acceptor. LgtC has also exhibited a strong preference in vitro for the correct donor epimer, exhibiting a 3400-fold decrease in k cat when UDP-Glc was used instead of UDP-Gal (18) . A rare exception to this rule, CstII has been shown in vivo and in vitro to utilize KDN as a donor in addition to sialic acid, albeit at much reduced efficiency (19) .
The selectivity for acceptor substrates is not as predictable. Crystal structures and a proposed reaction mechanism are available for one CAZy family 8 representative, the LgtC The ordered bi-bi kinetics of LgtC indicates that the donor sugar nucleotide binds to the protein first, followed by the acceptor substrate. Additionally, the crystal structure shows the donor enclosed in a binding pocket (20) . If the closing of the donor binding pocket creates the binding site for the acceptor, then any perturbation in this conformation could potentially affect interaction with the acceptor and therefore the K M(LPS) . This could explain the different K M(LPS) values obtained from His 6 -WaaJ using UDP-Gal vs. UDP-Glc donors.
Despite the relationships within the CAZy family 8, sequence comparisons do not shed light onto the molecular bases for substrate specificity. The amino acid sequences of the CAZy family 8 glycosyltransferases WaaR, WaaT, and WaaJ only share ~40% identity, most of which is located in regions of high conservation such as the DXD motifs. While mutagenesis of these regions in these proteins has not been performed, this degree of conservation argues that the roles are also conserved. These motifs have been investigated in LgtC, a galactosyltransferase involved in the biosynthesis of the lipooligosaccharide from Neisseria meningitidis (20) (21) (22) . The first DXD motif is predicted to be involved in the binding of the divalent metal ion, while the first aspartate (Asp 188) of the second DXD motif is involved in interactions with the galactose ring of the UDP-Gal donor. In the first crystal structure, these are direct contacts (20) , while in the second crystal structure, these are indirect contacts (18) . The true role of the second aspartate (Asp 190) in the second DXD motif is also unclear: in the first structure, it is rotated several angstroms away from the anomeric carbon, leading to the proposal of an S N i reaction mechanism involving Gln 189 (20) . However, this second aspartate was identified by mass spectrometry as the amino acid covalently linked to the donor sugar when UDP-Glc or UDP-Gal was incubated with the Q189E mutant enzyme (18) .
These crystal structures were solved with donor analogs, rather than physiological donor and acceptor substrates. Therefore the differing results can be resolved if there is a significant reorganization of the active site during catalysis, allowing Asp 190 to attack the anomeric carbon.
His 6 -WaaJ exhibited lower in vitro activity with CWG309 (waaT::aacC1) LPS than with its native acceptor but was still able to catalyze full extension of both acceptors in vivo, based on observations from PAGE and NMR studies. In contrast, His 6 -WaaT showed similar in vitro activity against CWG350 (waaJ::aacC1) LPS and its native acceptor. The activity of these two family 8 enzymes using non-native acceptors is perhaps surprising but may reflect the genetic backgrounds in which these enzymes have evolved. WaaT is never naturally found in E. coli containing the WaaI enzyme (which adds Gal to the growing acceptor; see Figure 1 and (4)). Similarly, WaaJ is never found in E. coli containing the corresponding WaaO enzyme (which adds Glc; Fig. 1 ). Since these enzymes see only one acceptor type, the need for discrimination between acceptors is limited. In contrast, the enzymes occupy an environment where both potential donors (UDP-Glc and UDP-Gal) are present, so the need for stringent selection of donor is clear. The fact that the enzymes incorporated their correct donor sugars even in non-natural cellular backgrounds containing different LPS acceptor structures demonstrates the power of this donor specificity.
Interestingly, neither His 6 -WaaJ nor His 6 -WaaT could extent the LPS in CWG308 (waaO::aacC1). This may reflect an apparent requirement for an acceptor of minimal size. This is also supported by the observation that His 6 -WaaJ did not elongate FCHASE-Gal or FCHASE-Lac synthetic acceptors (6) . However, the potential impact of altered conformation in the shorter acceptor resulting from its proximity to the inner core (heptose residue) must also be taken into account.
The results presented here for a group of related CAZy family 8 glycosyltransferases indicate that the enzymes may have more flexibility for both donor and acceptor than anticipated, when studied in vitro. However, the extent of this flexibility is limited in vivo due to the strict preference for a specific donor. These observations have significance for both in vitro and in vivo glycoengineering applications.
Furthermore, the flexibility of these glycosyltransferase enzymes seen in vivo experiments suggests a need for caution in interpreting genetic "complementation" data if the product analyses are confined to LPS PAGE profiles. While a residue may be added at a particular point in the extension process to support product completion, the identity of the added residue may only be established by further structural analysis.
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Heinrichs a The CWG309 structure is reproduced from (8). 
